Literature DB >> 27833103

Acute myeloid leukemia therapy and the chosen people.

E Estey1, R P Gale2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27833103     DOI： 10.1038/leu.2016.306

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  21 in total

1.  Cancer Drugs Approved on the Basis of a Surrogate End Point and Subsequent Overall Survival: An Analysis of 5 Years of US Food and Drug Administration Approvals.

Authors:  Chul Kim; Vinay Prasad
Journal:  JAMA Intern Med       Date:  2015-12       Impact factor: 21.873

2.  Acute myeloid leukemia, version 2.2013.

Authors:  Margaret R O'Donnell; Martin S Tallman; Camille N Abboud; Jessica K Altman; Frederick R Appelbaum; Daniel A Arber; Eyal Attar; Uma Borate; Steven E Coutre; Lloyd E Damon; Jeffrey Lancet; Lori J Maness; Guido Marcucci; Michael G Martin; Michael M Millenson; Joseph O Moore; Farhad Ravandi; Paul J Shami; B Douglas Smith; Richard M Stone; Stephen A Strickland; Eunice S Wang; Kristina M Gregory; Maoko Naganuma
Journal:  J Natl Compr Canc Netw       Date:  2013-09-01       Impact factor: 11.908

3.  Correlation between peripheral blood and bone marrow regarding FLT3-ITD and NPM1 mutational status in patients with acute myeloid leukemia.

Authors:  Wei-Gang Tong; Vicky K Sandhu; Brent L Wood; Paul C Hendrie; Pamela S Becker; John M Pagel; Roland B Walter; Elihu H Estey
Journal:  Haematologica       Date:  2014-12-19       Impact factor: 9.941

4.  A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials.

Authors:  G Montalban-Bravo; X Huang; K Naqvi; E Jabbour; G Borthakur; C D DiNardo; N Pemmaraju; J Cortes; S Verstovsek; T Kadia; N Daver; W Wierda; Y Alvarado; M Konopleva; F Ravandi; Z Estrov; N Jain; A Alfonso; M Brandt; T Sneed; H-C Chen; H Yang; C Bueso-Ramos; S Pierce; E Estey; Z Bohannan; H M Kantarjian; G Garcia-Manero
Journal:  Leukemia       Date:  2016-10-31       Impact factor: 11.528

5.  A case for Bayesianism in clinical trials.

Authors:  D A Berry
Journal:  Stat Med       Date:  1993-08       Impact factor: 2.373

6.  Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment.

Authors:  Roland B Walter; Megan Othus; Gautam Borthakur; Farhad Ravandi; Jorge E Cortes; Sherry A Pierce; Frederick R Appelbaum; Hagop A Kantarjian; Elihu H Estey
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

7.  Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia.

Authors:  P Anderlini; R S Benjamin; F C Wong; H M Kantarjian; M Andreeff; S M Kornblau; S O'Brien; B Mackay; M S Ewer; S A Pierce
Journal:  J Clin Oncol       Date:  1995-11       Impact factor: 44.544

Review 8.  Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

Authors:  Hartmut Döhner; Elihu H Estey; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Alan K Burnett; Hervé Dombret; Pierre Fenaux; David Grimwade; Richard A Larson; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel A Sanz; Jorge Sierra; Martin S Tallman; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

9.  Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD Anderson.

Authors:  M Othus; H Kantarjian; S Petersdorf; F Ravandi; J Godwin; J Cortes; S Pierce; H Erba; S Faderl; F R Appelbaum; E Estey
Journal:  Leukemia       Date:  2013-06-13       Impact factor: 11.528

10.  Pragmatic Trials.

Authors:  Ian Ford; John Norrie
Journal:  N Engl J Med       Date:  2016-08-04       Impact factor: 91.245
View more
  3 in total

Review 1.  Cytotoxic therapy in acute myeloid leukemia: not quite dead yet.

Authors:  Laura C Michaelis
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  How good are we at predicting the fate of someone with acute myeloid leukaemia?

Authors:  E Estey; R P Gale
Journal:  Leukemia       Date:  2017-03-17       Impact factor: 11.528

Review 3.  Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects.

Authors:  Jan-Niklas Eckardt; Martin Bornhäuser; Karsten Wendt; Jan Moritz Middeke
Journal:  Blood Adv       Date:  2020-12-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.